Trial
NCT00102128
Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Genzyme, a Sanofi Company
Collaborators
—
Condition
Ischemic Heart Failure
Intervention
Cellular Therapy (Cultured Autologous Skeletal Myoblast Transplantation)
Why stopped
DMC recommended stop
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-22